The Swedish Prison Program is an Intervention Prevention Program Targeting Injecting Drug Users Risk Behaviours and Infectious Diseases

Having Ever Injected Drugs Clinical Trial

— SHP  

Official title:

Svenska Häktesprogrammet, Prevention, Risk Behaviour and Infectious Diseases Among IDU.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02234167
• Other study ID #: Swedish Prison Program
• Status: Completed
• Phase: N/A
• Start date: April 2002
• Est. completion date: December 31, 2013

Study information

• Verified date: September 2020
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the Swedish Prison Program which started back in 1987 and up until 2009 was called "The Social Medicine Remand Prison Project" is to target injecting drug users (IDU) with primary and secondary health interventions with regards to injecting and sexual risk behaviours and infectious diseases such as hepatitis C and B, HIV and sexually transmitted infections (STI).

The overall aim is to assess the effect of different prevention efforts on HIV/HCV risk behaviour and disease outcome among IDUs over time.

Description:

Risk behaviour for IDU is sexual risk taking, i.e., sex without a condom, buying or selling sex and injection risk taking, i.e., sharing needle, syringe or paraphernalia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: December 31, 2013
• Est. primary completion date: December 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Defined as an injecting drug user, in the prison and probation service and agree to anonymously participate

Exclusion Criteria:

• Being defined as a non-drug user, non-injecting drug user

Related Conditions & MeSH terms

• Communicable Diseases
• Having Ever Injected Drugs
• Infection

Intervention

Behavioral:
• Risk behaviour and infectious diseases
through counselling, testing vaccination

Locations

Country	Name	City	State
Sweden	SHP	Stockholm

Sponsors (4)

Lead Sponsor	Collaborator
Karolinska Institutet	Linkoeping University, Public Health Agency of Sweden, Swedish Prison and Probation Service

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of participants with injection risk behaviour	Have you received already used injection equipment from someone last 12 months Have you lent (away) already used injection equipment to someone last 12 months Have you shared solution and/or filter with someone last 12 months Number of people shared needles with last month Number of injections last month Number of Hepatitis C positive Number of HIV positive Number of Hepatitis B positive Number of respondenst positive for sexually transmitted infections	2002-2012
Secondary	Number of participants with infectious diseases	HIV, HCV, HBV and STI	2002-2012